|
|
Not long ago, Elon Musk's "masterpiece" — Neuralink's brain implant chip — brought exciting news once again! According to Musk, the first human patient implanted with the brain-machine interface chip has fully recovered. Even more exhilarating is the fact that he can control the computer mouse cursor with his thoughts.
It's widely known that Neuralink's goal is to treat neurological diseases by implanting chips in the brain, including Alzheimer's, dementia, and spinal cord injuries. The ultimate vision is to achieve integration between humans and artificial intelligence. In September last year, Neuralink received approval from an independent review committee and began recruiting patients with spinal cord injuries or amyotrophic lateral sclerosis (ALS) for trials. Last month, Musk announced that the first human patient had been successfully implanted with the Neuralink brain-machine interface chip and was recovering well.
The latest news indicates that the patient can now move the mouse cursor on the screen just by thinking, which is a significant advancement. Next, Neuralink is attempting to enable patients to perform more complex operations, such as moving the mouse left, right, up, down, and dragging objects, solely through their thoughts. Neuralink's research involves the use of robots to surgically implant the brain-machine interface into the areas of the brain responsible for movement.
Preliminary success suggests that Neuralink may have reached a significant milestone. However, specific details of scientific progress are not yet clear, as Musk has not provided more information or evidence of surgical outcomes. Although this is positive news, the road to commercializing brain implants may still be long. Typically, initial human trials recruit 5 to 10 subjects and take about 6 months. If successful, Neuralink will begin feasibility studies and ultimately conduct pivotal studies before final approval for market release. |
|
Post time 28-2-2024 21:31:27